Biotech

All Articles

Rivus' period 2 obesity-related heart failure trial attacks endpoint

.Rivus Pharmaceuticals has actually plumped up the prospects of its own fat-busting, muscle-sparing ...

Ovid halts preclinical work, IV program after soticlestat stop working

.Ovid Rehab presently exposed last month that it was trimming its headcount as the firm browses an u...

Eli Lilly opens up $700M nucleic acid R&ampD center in Boston ma Port

.Eli Lilly has opened up a $700 thousand R&ampD facility in the Boston Seaport, enhancing its own RN...

Boundless Bio makes 'small' layoffs 5 months after $100M IPO

.Simply 5 months after securing a $100 million IPO, Vast Bio is already laying off some staff member...

Halda's $126M is going to progress 'secure and also kill' tumor medications

.The initial phases of oncology R&ampD aren't except intriguing brand new techniques, and Halda Ther...

Lykos 'remorses' not divulging research transgressions with author

.Psychopharmacology has actually taken 3 write-ups concerning midstage professional trial informatio...

Analysts examine Avidity's DMD win, uncovering subtleties in information

.Avidity Biosciences amazed entrepreneurs with phase 1/2 information in Duchenne muscular dystrophy ...

Actinogen's cortisol blocker falls short stage 2 anxiety research study

.Actinogen Medical's cortisol blocker has actually skipped the major endpoint of a period 2 study in...

Bivictrix determines going exclusive only way to take ADC into center

.Antibody-drug conjugates (ADCs) have actually been at the facility of lots of a billion-dollar biob...

TPG leadings up funds to $580M for assets throughout life scientific researches

.Property supervisor TPG, which has sustained biotechs such as Sionna Rehabs as well as Santa Clam A...